MiniMed Group, Inc. (MMED)

MiniMed Group Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Year Ending	TTM	Apr 25, 2025	Apr 25, 2024	Apr 25, 2023
Net Income	-196	-213	-112	-96
Depreciation & Amortization	153	143	129	115
Share-Based Compensation	-	41	38	35
Other Operating Activities	57	154	-19	-64
Operating Cash Flow	14	140	41	-6
Operating Cash Flow Growth	-	241.46%	-	-
Capital Expenditures	-221	-193	-148	-167
Change in Investments	-	-	-8	-13
Other Investing Activities	-10	-	-1	-
Investing Cash Flow	-231	-193	-157	-180
Other Financing Activities	215	10	112	185
Financing Cash Flow	215	10	112	185
Net Cash Flow	-1	-43	-4	-1
Free Cash Flow	-207	-53	-107	-173
Free Cash Flow Margin	-7.17%	-1.95%	-4.33%	-7.71%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).